Lexaria Bioscience Corp.
LEXX
$1.47
$0.1178.67%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.75% | -22.62% | -174.32% | 44.92% | 4.84% |
| Total Depreciation and Amortization | 61.29% | 13.76% | -3.11% | -43.32% | -51.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.97% | -77.44% | 5,252.56% | -92.32% | -59.55% |
| Change in Net Operating Assets | -201.78% | 128.18% | 19,175.00% | 99.72% | 79.93% |
| Cash from Operations | -44.10% | -49.41% | -104.34% | 47.57% | 27.13% |
| Capital Expenditure | 42.79% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.38% | -20.91% | 61.40% | -42.50% | 41.52% |
| Cash from Investing | 45.69% | -216.36% | 61.40% | -42.50% | 41.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 46.06% | 89.78% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 46.06% | 89.78% | 1,594.99% |
| Foreign Exchange rate Adjustments | -252.38% | 275.00% | 95.20% | -668.18% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 180.56% | -152.19% | 36.44% | 356.93% | 133.23% |
